| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-85 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4738 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate |
2004-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_983581d4b9a3f414649fedd2c1399ca7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dd1dfda959c11eac6a0ea240784bc0d |
| publicationDate |
2004-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004253215-A1 |
| titleOfInvention |
Methods and compositions for treating disorders |
| abstract |
Methods and compositions for producing targeted delivery vectors are provided. Such vectors are useful for treating neoplastic disorders. Also provided are protocols for administering targeted delivery vectors in a clinical setting such that a therapeutic effect is achieved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2077862-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009123428-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9017659-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006253262-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8828378-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007178066-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2077862-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020210829-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101278841-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008054826-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012027727-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010233127-A1 |
| priorityDate |
2003-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |